← Retour
CanSino CEO Xuefeng Yu on Earnings, Pipeline
Source : Bloomberg28 août 2026Score de confiance : 48%
Xuefeng Yu, Chairman & CEO of CanSino Biologics, discusses the Chinese vaccine maker's first-half results and clinical pipeline. He speaks exclusively on "Bloomberg: The China Show." (Source: Bloomberg)